Zeda announced today that it agreed to acquire The Orthopaedic Implant Company (OIC) for an undisclosed amount.
San Francisco-based Zeda says the acquisition marks a “significant leap forward” in strengthening its commitment to “revolutionizing manufacturing and distribution of medical devices globally.”
OIC delivers high-quality, cost-effective orthopedic devices, Zeda said in a news release. The company believes the acquisitions enables it to produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible, high-value trauma implants to patients.
Itai Nemovicher, OIC co-founder and CEO, said Zeda shares the company’s values in advancing access to critical orthopedic care. Nemovicher said that, under Zeda, OIC could “reach new heights” in providing orthopedic solutions in the U.S. and abroad.
Under the terms of the acquisition, OIC will operate worldwide as a Zeda Health …